Stay updated with breaking news from Genscript Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NANJING, China, Jan. 4, 2024 /PRNewswire/ -- On January 10, 2024, the GenScript Biotech Global Forum is set to inaugurate with grandeur during the 42nd J.P. Morgan Healthcare Conference in San...
Conference to convene gene- and cell-therapy thought leaders from the research, industry, and capital communities as well as representatives from regulatory bodies PISCATAWAY, N.J., Dec. 14, 2023...
NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and...
NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and imagination. Particularly in the field of cellular gene therapy, a series of recent positive developments have been overwhelming. Recently, the world's first CRISPR/Cas9 gene editing therapy received market approval in the UK....
Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) saw a significant drop in short interest in November. As of November 15th, there was short interest totalling 4,376,100 shares, a drop of 7.4% from the October 31st total of 4,726,000 shares. Based on an average daily volume of 61,000 shares, the days-to-cover ratio is currently 71.7 […]